Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Financing › Details

Harpoon Therapeutics–SEVERAL: investment, 201812– IPO $86m FILED


Period Period 2018-12-27
Region Region United States (USA)
  Predecessor Harpoon Therapeutics–SEVERAL: investment, 201811 financing round Series C $70m led by OrbiMed
Organisation Money taker Harpoon Therapeutics Inc.
Products Product TriTAC™ imunno-oncology platform (tri-specific T-cell activating construct immuno-oncology platform)
  Product 2 investment banking

Record changed: 2019-03-14


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Harpoon Therapeutics Inc.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top